Your browser doesn't support javascript.
loading
Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.
Harada, N; Hiramatsu, N; Oze, T; Morishita, N; Yamada, R; Hikita, H; Miyazaki, M; Yakushijin, T; Miyagi, T; Yoshida, Y; Tatsumi, T; Kanto, T; Kasahara, A; Oshita, M; Mita, E; Hagiwara, H; Inui, Y; Katayama, K; Tamura, S; Yoshihara, H; Imai, Y; Inoue, A; Hayashi, N; Takehara, T.
Afiliación
  • Harada N; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
J Viral Hepat ; 21(5): 357-65, 2014 May.
Article en En | MEDLINE | ID: mdl-24716638

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Polietilenglicoles / Ribavirina / Interferón-alfa / Carcinoma Hepatocelular / Hepatitis C Crónica / Alanina Transaminasa Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Polietilenglicoles / Ribavirina / Interferón-alfa / Carcinoma Hepatocelular / Hepatitis C Crónica / Alanina Transaminasa Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2014 Tipo del documento: Article